Lora Humphrey Beebe, PhD, APRN, BC, is Associate Professor, College of Nursing, University of Tennessee, Knoxville, TN.
1744-6163/asset/bannerforeground.gif?v=1&s=2779e86a523917dff72668f54aec4b03fe8c6679)
Obesity in Schizophrenia: Screening, Monitoring, and Health Promotion
Article first published online: 26 DEC 2007
DOI: 10.1111/j.1744-6163.2008.00144.x
Additional Information
How to Cite
Beebe, L. H. (2008), Obesity in Schizophrenia: Screening, Monitoring, and Health Promotion. Perspectives in Psychiatric Care, 44: 25–31. doi: 10.1111/j.1744-6163.2008.00144.x
Publication History
- Issue published online: 26 DEC 2007
- Article first published online: 26 DEC 2007
- Abstract
- Article
- References
- Cited By
Keywords:
- Antipsychotic medications;
- lifestyle interventions;
- obesity;
- schizophrenia
PURPOSE.This paper reviews risks, assessments, antipsychotic medication choices, and lifestyle interventions for obesity in persons with schizophrenia.
CONCLUSIONS. Antipsychotic medication is the most important treatment choice. Simple diet teaching must take into account the cognitive limitations of clients with schizophrenia. After medical clearance is obtained, moderate exercise can be encouraged. Education about exercise benefits may increase motivation.
PRACTICE IMPLICATIONS. Nurses would be remiss to ignore the physical health effects of obesity in schizophrenia. Practitioners must choose psychiatric medications and provide health education, health promotion, and appropriate referrals to optimize quality of life for this group.